TY - JOUR
T1 - Propranolol blocks the hypophosphaturia of acute respiratory alkalosis in human subjects
AU - Tucker, R. R.
AU - Berndt, T. J.
AU - Thotharthri, V.
AU - Newcome, J.
AU - Joyner, M. J.
AU - Knox, F. G.
N1 - Funding Information:
From the Nephrotogy Research and General Clinical Research Units, Departments of Medicine, Physiology and Biophysics, and Anesthesia, Mayo Clinic and Foundation. Supported by the Mayo Foundation and by National Institutes of Health Grant MO1-RR00585. Presented in part at the'IXventy-sixth Annual Meeting of the American Society of Nephroiogy, Boston, Mass., 1994, and at the Thirty-seventh National Student Research Forum, Galveston, Tex., 1996.
PY - 1996
Y1 - 1996
N2 - Respiratory alkalosis (RA) is seen in diverse clinical conditions including tissue hypoxia, malignancy, neurologic disorders, febrile states, pregnancy, and hepatic failure. Acute RA causes hypophosphaturia in rats, and this effect on renal phosphate handling is reversed by β-adrenoreceptor antagonism. The objective of the present study was to determine the effect of acute RA on phosphate excretion in human patients in the absence and presence of β-adrenoreceptor antagonism with propranolol. Twelve normal volunteers, 6 women and 6 men, were studied in two phases, once with placebo and once with intravenous infusion of propranolol. In both groups, 30-minute renal clearances were taken during normoventilation (NV) and during acute RA induced by voluntary hyperventilation. Acute RA produced a significant decrease in plasma phosphate (P(Pl)) in the absence (ΔP(Pl) = -0.16 ± 0.03 mmol/L) and the presence (ΔP(Pl) = -0.16 ± 0.05 mmol/L) of propranolol. In the placebo group, fractional excretion of phosphate (FE(Pl)) decreased from 24.1% ± 3.4% in NV to 19.2% ± 2.6% in RA. This was associated with a significant decrease in parathyroid hormone (P(PTH)), from 3.38 ± 0.28 pmol/L in NV to 2.54 ± 0.30 pmol/L in RA. In the propranolol group, FE(Pl) did not change significantly, from 19.1% ± 2.7% in NV to 18.7% ± 3.0% in RA. This also occurred in the face of a decrease in P(PTH), from 4.39 ± 0.53 pmol/L in NV to 2.78 ± 0.33 pmol/L in RA. Thus propranolol selectively changes the response of FE(Pl) to acute RA while leaving the P(Pl) and P(PTH) responses unaltered. This suggests that β-adrenoreceptors play a role in the regulation of the response of renal phosphate handling during acute RA and that this role involves a direct tubular effect on phosphate reabsorption, independent of filtered load and hormonal status. We conclude that β-adrenoreceptor antagonism blunts the hypophosphaturic effect of acute respiratory alkalosis in human subjects.
AB - Respiratory alkalosis (RA) is seen in diverse clinical conditions including tissue hypoxia, malignancy, neurologic disorders, febrile states, pregnancy, and hepatic failure. Acute RA causes hypophosphaturia in rats, and this effect on renal phosphate handling is reversed by β-adrenoreceptor antagonism. The objective of the present study was to determine the effect of acute RA on phosphate excretion in human patients in the absence and presence of β-adrenoreceptor antagonism with propranolol. Twelve normal volunteers, 6 women and 6 men, were studied in two phases, once with placebo and once with intravenous infusion of propranolol. In both groups, 30-minute renal clearances were taken during normoventilation (NV) and during acute RA induced by voluntary hyperventilation. Acute RA produced a significant decrease in plasma phosphate (P(Pl)) in the absence (ΔP(Pl) = -0.16 ± 0.03 mmol/L) and the presence (ΔP(Pl) = -0.16 ± 0.05 mmol/L) of propranolol. In the placebo group, fractional excretion of phosphate (FE(Pl)) decreased from 24.1% ± 3.4% in NV to 19.2% ± 2.6% in RA. This was associated with a significant decrease in parathyroid hormone (P(PTH)), from 3.38 ± 0.28 pmol/L in NV to 2.54 ± 0.30 pmol/L in RA. In the propranolol group, FE(Pl) did not change significantly, from 19.1% ± 2.7% in NV to 18.7% ± 3.0% in RA. This also occurred in the face of a decrease in P(PTH), from 4.39 ± 0.53 pmol/L in NV to 2.78 ± 0.33 pmol/L in RA. Thus propranolol selectively changes the response of FE(Pl) to acute RA while leaving the P(Pl) and P(PTH) responses unaltered. This suggests that β-adrenoreceptors play a role in the regulation of the response of renal phosphate handling during acute RA and that this role involves a direct tubular effect on phosphate reabsorption, independent of filtered load and hormonal status. We conclude that β-adrenoreceptor antagonism blunts the hypophosphaturic effect of acute respiratory alkalosis in human subjects.
UR - http://www.scopus.com/inward/record.url?scp=0030257875&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030257875&partnerID=8YFLogxK
U2 - 10.1016/S0022-2143(96)80015-1
DO - 10.1016/S0022-2143(96)80015-1
M3 - Article
C2 - 8833892
AN - SCOPUS:0030257875
SN - 0022-2143
VL - 128
SP - 423
EP - 428
JO - Journal of Laboratory and Clinical Medicine
JF - Journal of Laboratory and Clinical Medicine
IS - 4
ER -